中国社区医师
中國社區醫師
중국사구의사
Chinese Community Doctors
2015年
33期
80-81
,共2页
强心保心方%慢性心力衰竭%临床观察
彊心保心方%慢性心力衰竭%臨床觀察
강심보심방%만성심력쇠갈%림상관찰
Qiang Xin Bao Xin direction%Chronic heart failure%Clinical observation
目的:观察强心保心方对冠心病慢性心力衰竭的临床疗效及对胱抑素 C、β2微球蛋白指标的影响.方法:将60例冠心病慢性心力衰竭患者随机分为治疗组和对照组.对照组给予西医常规治疗,治疗组在对照组的基础上给予强心保心方,治疗前后评价两组患者的中医证候、心功能分级、血清胱抑素C及β2微球蛋白变化情况.结果:治疗组疗效优于对照组.结论:在西医常规治疗基础上加用强心保心方治疗冠心病慢性心力衰竭的疗效优于单纯西医常规治疗,并且能预防肾脏病变,起到未病先防,既病防变之效.
目的:觀察彊心保心方對冠心病慢性心力衰竭的臨床療效及對胱抑素 C、β2微毬蛋白指標的影響.方法:將60例冠心病慢性心力衰竭患者隨機分為治療組和對照組.對照組給予西醫常規治療,治療組在對照組的基礎上給予彊心保心方,治療前後評價兩組患者的中醫證候、心功能分級、血清胱抑素C及β2微毬蛋白變化情況.結果:治療組療效優于對照組.結論:在西醫常規治療基礎上加用彊心保心方治療冠心病慢性心力衰竭的療效優于單純西醫常規治療,併且能預防腎髒病變,起到未病先防,既病防變之效.
목적:관찰강심보심방대관심병만성심력쇠갈적림상료효급대광억소 C、β2미구단백지표적영향.방법:장60례관심병만성심력쇠갈환자수궤분위치료조화대조조.대조조급여서의상규치료,치료조재대조조적기출상급여강심보심방,치료전후평개량조환자적중의증후、심공능분급、혈청광억소C급β2미구단백변화정황.결과:치료조료효우우대조조.결론:재서의상규치료기출상가용강심보심방치료관심병만성심력쇠갈적료효우우단순서의상규치료,병차능예방신장병변,기도미병선방,기병방변지효.
Objective:To observe the clinical curative effect of Qiang Xin Bao Xin direction in the treatment of coronary heart disease chronic heart failure and the influence on the cystatin C,beta 2 microglobulin index.Methods:60 patients with coronary heart disease chronic heart failure were randomly divided into the treatment group and the control group.The control group was given conventional western medicine treatment.The treatment group Qiang Xin Bao Xin direction on the basis of the control group. Before and after treatment,the TCM symptoms,heart function grading and serum cystatin C and beta 2 microglobulin changes of two groups were evaluated.Results:The curative effect of the treatment group was better than that of the control group.Conclusion:On the basis of conventional western medicine treatment,Qiang Xin Bao Xin direction in the treatment of patients with coronary heart disease chronic heart failure is better than western medicine routine treatment,and can prevention renal lesions,has the effect of prevention before disease onset and preventing disease from exacerbating.
